<DOC>
	<DOCNO>NCT02392351</DOCNO>
	<brief_summary>The REDUCE HTN : REINFORCE study conduct determine whether Vessix Reduce™ Catheter Vessix™ Generator treatment uncontrolled hypertension ( off-treatment office systolic blood pressure ≥150 mmHg ≤180 mmHg ) show acceptable performance 8 week compare masked procedure ( renal angiogram ) .</brief_summary>
	<brief_title>Renal Denervation Using Vessix Renal Denervation System Treatment Hypertension ( REDUCE HTN : REINFORCE )</brief_title>
	<detailed_description>Prospective , multicenter , single blind , randomize , control , pilot study . Subjects randomize renal denervation treatment mask renal angiogram procedure ( 2:1 ) .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<criteria>Age ≥18 ≤75 year OSBP ≥150 mmHg ≤180 mmHg base average 3 officebased blood pressure measurement Average 24hour ASBP ≥135 mmHg ≤170 mmHg For kidney , main renal artery , without accessory renal artery , diameter ≥3.0 mm ≤7.0 mm length ≥20.0 mm Agrees study procedure perform , competent willing provide write , informed consent Stenosis &gt; 30 % renal artery aneurysm either renal artery Fibromuscular dysplasia ( FMD ) Known cause secondary HTN Type 1 diabetes mellitus eGFR &lt; 40 mL/min/1.73m2 Known ejection fraction &lt; 30 % heart failure require hospitalization previous 6 month Severe valvular heart disease ≥1 episode ( ) orthostatic hypotension relate medication change ( reduction SBP ≥20 mmHg DBP ≥10 mmHg within three minute stand ) couple symptom within past year screening</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Renal Denervation</keyword>
</DOC>